Abstract:Charles B. Simone II New York Proton Center, New York, NY, USA Submitted Sep 25, 2024. Accepted for publication Sep 25, 2024. Published online Sep 26, 2024. doi: 10.21037/apm-24-141 The July 2024 issue of Annals of Palliative Medicine is a truly unique issue that includes articles from multiple different special series. Together, manuscripts from these special series and general manuscripts together comprise 3 Original Articles, 27 Review Articles, 5 Mini-Reviews, 3 Editorials, and 1 Case Report in this single journal issue. This Message From the Editor-in-Chief focuses on those special series, setting the stage for readers to enjoy these impactful collections of articles on several different timely topics in palliative medicine. First, Dr. Sukeshi Patel Arora and Dr. Sherri Rauenzahn Cervantez served as Guest Editors of a special series on the comprehensive care for patients with hepatocellular carcinoma (1). Hepatocellular remains one of the most common and most deadly malignancies. Incidence rates of liver cancers continue to increase, and although the median survival has improved over the past decade, liver cancers remain the third leading cause of death from cancer worldwide, with only a small minority of patients alive 5 years after their diagnosis (2). Hepatocellular carcinoma represents the majority of primary liver cancers, and there is renewed hope for improved outcomes in this patient population in the future with increased utilization of vaccinations for hepatitis B and improvements in treatment for hepatitis C, both of which are prominent etiologies for hepatocellular carcinoma (2). Currently, however, most patients with liver cancers continue to be diagnosed with advanced disease that is not conducive to curative-intent management (3). As a result, multidisciplinary and comprehensive care for patients with hepatocellular carcinoma are critical. The 2022 San Antonio Liver Cancer Symposium brought increased awareness to the palliative therapies employed for patients with hepatocellular carcinoma, and this special series in Annals of Palliative Medicine highlights those therapies. Articles by leaders in the fields of palliative care and liver malignancies focus on the management of cirrhosis and of hepatitis, the use of transplant, the treatment of localized and of multifocal disease, the role of radiation therapy, the use of immunotherapy and other novel therapeutics, rehabilitation, and multidisciplinary care for patients with hepatocellular carcinoma. Next, Dr. Pragnesh Patel, Dr. Lara Skarf, and Dr. Susan Nathan served as Guest Editors of a special series on outpatient palliative care in geriatric clinics (4). This is an increasingly critical segment of the population to focus on for palliative medicine given that the world population is aging, and that more older adults are living with multiple chronic diseases. These Guest Editors detail that there have been recent improvements in the quality of care provided to older adults, but the discuss several challenges that persist in providing optimal care, including several unique challenges in an elderly population. This special series provides readers with an overview of palliative care delivery relevant to specific conditions faced by the geriatric population—from advanced lung disease to advanced kidney disease to advanced cardiac disease to multimorbidity and frailty to human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) to cancer to dementia. Symptom management in these elderly patients is detailed, and several of the articles within the special series underscore a need for early integration of palliative care in the disease trajectory using a multidisciplinary team approach. The importance of early palliative care has been well detailed across a multitude of diseases and has been prominently featured in articles in this journal, including some even from a decade ago (5). Third, Dr. Anna Kitta and Dr. Eva Katharina Masel served as Guest Editors of a special series on narrative medicine in palliative care (6). Narrative medicine—as inspired by aspects of the humanities like literature, philosophy and art—is part of the medical humanities and focuses on the importance of narratives and stories in medicine. Medicine practiced with narrative competence is thought to be an optimal model for humane and effective medical practice. Narrative medicine can serve to bridge divides separating physicians from patients and their colleagues, providing for unique perspectives and opportunities for respectful, empathic, and nourishing medical care. (7,8). Narrative medicine is a relatively new concept—now just over 2 decades since its founding—and one that has, to date, been underreported in this journal, but it can be of critical importance in the journey that patients with chronic diseases face. This special series details the intersection between storytelling and h -Abstract Truncated-

Sixty Years of CA: A Cancer Journal for Clinicians

Five decades of advances in cancer research

A note from history: Landmarks in history of cancer, part 5

Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology

Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2

Two decades of advances in clinical oncology — lessons learned and future directions

Five decades of occupational cancer epidemiology

The flourishing scholarship of psychosocial oncology viewed across 30 years through the lens of this journal, Psycho-Oncology

Cancer chemotherapy: A critical analysis of its 60 years of history

CHINESE MEDICAL JOURNAL: A GLIMPSE OF THE PAST AND THE PRESENT

The AANS/CNS Section on Tumors: a summary of 40 years of advocacy to advance the care of patients with brain and spine tumors

Vol. 116, February 2018

Abstract 3555: COSMIC: two decades of curating somatic variants in cancer

The formative years: medical ethics comes of age

Introducing the “Virtual Tumor Board” series in CA: A Cancer Journal for Clinicians

Epstein–Barr virus at 60

The evolution of palliative medicine and its integration with oncology care

Clinical Chemistry and laboratory medicine: enjoying the present and assessing the future

Welcome to Seminars in Thrombosis and Hemostasis 2024: 50 Years of Publishing

Publisher’s Note: A New Chapter for Hematology Reports—Continued Publication by MDPI

Palliative therapies in hepatocellular carcinoma, palliative care in geriatric clinics, and the introduction of narrative medicine